I. Shchepotin

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor <i>KRAS</i> and <i>BRAF</i> Mutation Status

Eric Van Cutsem, Claus-Henning Köhne, István Láng et al. · Journal of Clinical Oncology · 2011 · 1.9K citations · Full text

Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial

Eric Van Cutsem, Marek P. Nowacki, István Láng et al. · Journal of Clinical Oncology · 2007 · 314 citations

Pathology, Pharmacotherapy, Crystal Trial +17

Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicin

A. V. Shevchenko, Andriy Romanov, M. Tselepi et al. · Nanomedicine Nanotechnology Biology and Medicine · 2014 · 98 citations

Nanoparticles, Magnetism, Nanomedicine +14

Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer.

Stephen R.T. Evans, Jose M. Nolla, John Hanfelt et al. · PubMed · 1998 · 91 citations

Oncology, Gastrointestinal Oncology, Medicine +13

Extended surgical resection in T4 gastric cancer

I. Shchepotin, Vyacheslav A. Chorny, Russell J. Nauta et al. · The American Journal of Surgery · 1998 · 83 citations · Full text